PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
2016 · Proceedings of the National Academy of Sciences · 805 citations
https://doi.org/10.1073/pnas.1521738113
J
Jing Lü
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
244
Papers
8.7K
Citations
45
h-index
137
i10-index
Jing Lü is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Advanced biosensing and bioanalysis techniques & Advanced Nanomaterials in Catalysis & Electrochemical sensors and biosensors. The author has an h-index of 45, co-authored 208 publications.
ORCID: 0000-0001-5766-2775Papers by this author
worksCancer Cell Stiffness: Integrated Roles of Three-Dimensional Matrix Stiffness and Transforming Potential
2010 · Biophysical Journal · 154 citations
https://doi.org/10.1016/j.bpj.2010.07.051
Mitotic Deregulation by Survivin in ErbB2-Overexpressing Breast Cancer Cells Contributes to Taxol Resistance
2009 · Clinical Cancer Research · 79 citations
https://doi.org/10.1158/1078-0432.ccr-08-0954
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants
2023 · Nature Communications · 52 citations
https://doi.org/10.1038/s41467-023-38751-8
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
2020 · Acta Pharmaceutica Sinica B · 49 citations
https://doi.org/10.1016/j.apsb.2020.10.017
The NAD+-dependent protein deacetylase activity of SIRT1 is regulated by its oligomeric status
2012 · Scientific Reports · 46 citations
https://doi.org/10.1038/srep00640
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat